FIELD: medicine, proctology, urology, obstetrics, gynecology, pediatrics, gastroenterology, oncology, therapy, surgery.
SUBSTANCE: invention proposes two variants of agent "Bifiliz-C" for treatment and prophylaxis of dysbacteriosis and inflammatory diseases in abdomen organs and small pelvis. By the first variant agent comprises Bifiliz dry (VIGEL) in a single dose in the amount 1-5 doses that comprises additionally solid fat in the amount 1.0-2.0 g as the complex synthetic structure-forming base and represents suppository designated for rectal and intravaginal applying. By the second variant agent comprises additionally vitamin E (alpha-tocopherol) in the amount 2-10 mg per a suppository. Agent provides the enhanced absorbability of lyzozyme from intestine and enhanced prophylaxis and treatment of dysbacteriosis.
EFFECT: valuable medicinal properties of agent.
3 cl, 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR DISBACTERIOSIS TREATMENT | 1997 |
|
RU2123345C1 |
| COMPOSITION FOR TREATMENT OF PATIENTS WITH DISBACTERIOSIS, SECONDARY IMMUNODEFICIENCY AND MINERAL DISORDER IN ALLERGO-DERMATOSIS AND METHOD OF TREATMENT | 2000 |
|
RU2166321C1 |
| AGENT FOR DISBACTERIOSIS TREATMENT AND PROPHYLAXIS | 1994 |
|
RU2071339C1 |
| MEDICATION FOR PREVENTION AND TREATMENT OF NORMAL MICROFLORA DISTURBANCES (DISBACTERIOSES) | 2009 |
|
RU2410112C1 |
| METHOD FOR PREVENTING PERITONEAL ADHESIONS OF A FEMALE PELVIS | 2020 |
|
RU2741247C1 |
| AGENT "LIZOLAKT" POTENTIATING ANTITUMOR ACTIVITY OF CYTOTOXIC PREPARATIONS | 2006 |
|
RU2311196C1 |
| CURATIVE-PROPHYLACTIC PREPARATION IN SOLID AND SOFT FORMS AND METHOD OF PROPHYLAXIS AND TREATMENT OF PATIENTS WITH DYSBACTERIOSIS AND UROGENITAL INFECTIONS | 1999 |
|
RU2146526C1 |
| METHOD OF TREATING CHRONIC INFLAMMATORY PELVIC DISEASES | 2010 |
|
RU2445988C1 |
| IMMUNOBIOTIC COMPLEX | 2016 |
|
RU2706069C2 |
| METHOD OF ACUTE BACTERIAL VAGINITIS TREATMENT | 2008 |
|
RU2391977C2 |
